UK markets close in 5 hours 20 minutes

Titan Medical Inc. (TMDI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5792+0.0092 (+1.61%)
At close: 04:00PM EST
0.5800 +0.00 (+0.14%)
After hours: 05:14PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 80.65M
Enterprise value 39.52M
Trailing P/E 26.45
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.66
Price/book (mrq)3.17
Enterprise value/revenue 1.97
Enterprise value/EBITDA -0.77

Trading information

Stock price history

Beta (5Y monthly) 4.72
52-week change 3-79.42%
S&P500 52-week change 317.58%
52-week high 33.3000
52-week low 30.5000
50-day moving average 30.7096
200-day moving average 31.4141

Share statistics

Avg vol (3-month) 3781.39k
Avg vol (10-day) 3370.28k
Shares outstanding 5110.93M
Implied shares outstanding 6N/A
Float 8111.05M
% held by insiders 10.22%
% held by institutions 14.53%
Shares short (30 Dec 2021) 4312.5k
Short ratio (30 Dec 2021) 40.5
Short % of float (30 Dec 2021) 40.28%
Short % of shares outstanding (30 Dec 2021) 40.28%
Shares short (prior month 29 Nov 2021) 4507.69k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Jun 2018
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 318 Jun 2018

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin -223.57%
Operating margin (ttm)-123.10%

Management effectiveness

Return on assets (ttm)-39.51%
Return on equity (ttm)-308.06%

Income statement

Revenue (ttm)20.09M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)20M
EBITDA -24.45M
Net income avi to common (ttm)-44.92M
Diluted EPS (ttm)-0.4470
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)44.68M
Total cash per share (mrq)0.4
Total debt (mrq)3.54M
Total debt/equity (mrq)13.91
Current ratio (mrq)1.97
Book value per share (mrq)0.23

Cash flow statement

Operating cash flow (ttm)-24.33M
Levered free cash flow (ttm)-14.22M